Abstract
Xenotransplantation today is characterized by uncertainty and differences of opinion. The science, in the laboratory, is progressing at a satisfactory pace, with a number of advances; at the same time, however, the science is also indicating that there are significant potential risks.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Acute Services Policy Unit. 1994. “Identification of Potential Donors of Organs for Transplantation” London: Department of Health {HSG(94)1}.
AGEX. Advisory Group on the Ethics of Xenotransplantation. 1997. Animal Tissues into Humans, London: London Stationery Office.
Allan, J.S. 1998. “The Risk of Using Baboons as Transplant Donors. Exogenous and Endogenous Retroviruses” Ann. NY Acad. Sci., Vol. 862, pp. 87–99.
Allan, J.S. et al. 1996. “Letter to T.W. Beth” Food and Drug Admin. USA, Dec. 20. Re: Draft PHS guidelines. Document no. 96M-0311.
Arnold, R.M. & Youngner, S.J. (Eds.) 1993. ‘Ethical, Psychological, and Public Policy Implication of Procuring Organs from Non-Heart-Beating Cadavers“ Special Issue, Kennedy Institute of Ethics Journal, Vol. 3(2), pp. 103–277.
ASTP. American Society of Transplant Physicians. 1996. Comments from the Xenotransplant Committee of the ASTP. Wayne Hancock, Chair. http://www.ASTP.org(posted Dec. 22, 1996).
Bach, F.H. & Fineberg, H.V. 1998. “Call for Moratorium on Xenotransplants” Nature, Vol. 391(6665), p. 326.
Bach, F.H. et al. 1998. “Uncertainty in Xenotransplantation: Individual Benefit Versus Collective Risk” Nat Med, Vol. 4(2), pp. 141–144.
Bailey, L.L. et al. 1985. “Baboon to Human Cardiac Xenotransplantation in a Neonate” JAMA, Vol. 254, p. 3321.
Butler, D. 1998. “Briefing” Nature, Jan. 22.
Butler, D. 1999a. “Pig in the middle” Nature, Vol. 397, p. 279.
Butler, D. 1999b. Transplant panel “Could be Model for Ethics Thinktank.”
Caplan, A.L. 1992. “Is Xenotransplantation Morally Wrong?” Transplant Proc, Vol. 24(2), pp. 722–727.
Chapman, L.E. 1996. Presentation to the Conference on Xenograft Transplantation: Science, Ethics and Public Policy. Institute of Medicine. June 25–27, 1997, p. 15.
Chapman, L.E. et al. 1995. “Xenotransplantation and Xenogeneic Infections” N Eng. J Med., Vol. 333, pp. 1498–1501.
CNN. 1999. “Advisers Propose Rules for Stem Cell Research” CNN Interactive. Web posted at: 11.-45 AM EDT. Associated Press. April 9.
Collins, B.H., Parker, W. & Platt, J.L. 1994. “Characterization of Porcine Endothelial Cell Determinants Recognized by Human Natural Antibodies” Xenotransplantation, Vol. 1, pp. 36–46.
Council on Scientific Affairs. 1985. “Xenografts: Review of the Literature and Current Status” JAMA, Vol. 254, pp. 3353–3357.
Cozzi, E. et al. 1997. “Effect of Transgenic Expression of Human Decay-Accelerating Factor on the Inhibition of Hyperacute Rejection of Pig Organs” Xenotransplantation: The Transplatation of Organs and Tissues between Species, D.K.C. Cooper, E. Kemp, J.L. Platt & D.J.G. White (Eds.), Berlin: Springer-Verlag, pp. 665–682.
Daar, A.S. 1999. “Animal-to-Human Organ Transplants-A Solution or a New Problem?” (Round Table), World Health Bulletin, Vol. 77(1), pp. 54–81.
Daar, A.S. 1998. ‘Analysis of Factors for the Prediction of the Response to Xenotransplantation“ Ann. N.Y. Acad. Sci., Vol. 862, pp. 222–233.
Daar, A.S. 1995. “Living-Organ Renal Donation: Time for a Donor Charter” Clinical Transplants (1994), UCLA, pp. 376–380.
Daar, A.S. I997a. “Xenotransplants: Proceed with Caution” Nature, Vol. 392, p. 11.
Daar, A.S. 1997b. “Ethics of Xenotransplantation: Animal Issues, Consent and Likely Transformation of Transplant Ethics” World J Surgery, Vol. 21, pp. 975–982.
Daar, A.S. et al. 1997. “Living-Donor Renal Transplantation: Evidence-Based Justification for an Ethical Option” Transplantation Reviews, Vol. 11, pp. 95–108.
Daar, A.S. & Sells, R.A. 1990. “Living Non Related Donor Renal Transplantation -A Reappraisal” Transplantation Reviews, Vol. 4(2), pp. 128–140.
Daar, A.S. 1994a. “Xenotransplantation and Religion: The Major Monotheistic Religions” Xeno, Vol. 2(4), pp. 61–64.
Daar, A.S. 1994b. “Transplantation in Developing Countries” Kidney Transplantation, Principles and Practice, 4th ed., P.J. Morris (Ed.), Philadelphia: Saunders, pp. 478–503.
Deacon, T. et al. 1997. “Histological Evidence of Pig Neural Cell Survival After Transplantation into a Patient with Parkinson’s Disease” Nature Medicine, Vol. 3, pp. 350–353.
DHHS. 1999. Department of Health and Human Services. Food and Drug Administration. Center for Biologics Evaluation and Research (CBER). April Guidance For Industry. Public Health Issues Posed by the Use of Non-human Primate Xenografts in Humans. (Available from the Office of Communication, Training and Manufacturers Assistance (HFM-40), 1401 Rockville Pike, Rockville, MD 20852–1448. U.S.)
Ethics Committee, The International Transplantation (Sheil, A.G.R. et al.) Society 1997. “The Transplantation Society and Xenotransplantation” Transplantation Soc. Bulletin Issue 6, pp. 11–14.
Good, A.H. et al. 1992. “Identification of Carbohydrate Structures that Bind Human Antiporcine Antibodies: Implications for Discordant Xenografting in Humans” Transpl. Proc., Vol. 24, pp. 559–562.
Groth, C.G. et al. 1994. “Transplantation of Porcine Fetal Pancreas to Diabetic Patients” Lancet, Vol. 344, pp. 1402–1404.
Hammer, C. 1998. “Physiological Obstacles After Xenotransplantation” Ann. NY Acad. Sci., Vol. 862, pp. 19–27.
Heneine, W. et al. 1998. “Identification of a Human Population Infected with Simian Foamy Viruses” Nature Medicine, Vol. 4(4), pp. 403–407.
IOM. Institute of Medicine. 1996. Xenotransplantation: Science, Ethics and Public Policy. Washington, D.C.: National Acad. Press.
Jakobovitz, I. 1975. Jewish Medical Ethics, New York: Bloch Publishing Co.
La Prairie, A. 1999. “Current Information on the Status of Xenotransplantation in Canada” Personal Communication, April 28, 1999.
LeTissier, P. et al. 1997. “Two Sets of Human-Tropic Pig Retrovirus. Scientific Correspondence” Nature, Vol. 389, pp. 681–682.
Lock, M. 1996. “Ideologies and Brain Death in Japan” Organ Transplantation: Meaning and Realities.
S.J. Youngner, R.C. Fox & L.J. O’Connel (Eds.), Madison: Univ. Wisconsin Press, pp. 142–167.
Morris, P.J. 1999. quoted in: “Claims Animal Organ Transplants Unlikely” Australian Broadcasting Corp. Online News. Monday 8 March, 1999. Comments apparently made at the 12th Biennial Congress of the Asian Surgical Association in Brisbane, March, 1999.
Mudur, G. 1999. “Indian Surgeon Challenges Ban on Xenotransplantation” News, BMJ, Vol. 318, p. 79.
Mukherjee, M. 1997. “Trends in Animal Research” News Scientist, Feb.
Nature. 1998. Opinion. “Halt the Xeno-Bandwagon. Xenotransplantations Risk Makes Moratorium Essential” Nature, Vol. 391, p. 309.
Nature. 1995. “Aids Patient Given Baboon Bone Marrow” Nature, Vol. 378, p. 756.
Nuffield Council on Bioethics. 1996. Animal-to-Human Transplants. The Ethics of Xenotransplantation, London: Nuffield Council on Bioethics.
O’Riardan, T. & Jordan, A. 1995. “The Precautionary Principle in Contemporary Environmental Politics” Environmental Values, Vol. 4, pp. 191–212.
OECD. 1998. Policy Considerations on International Issues in Transplantation Biotechnology Including the use of Non-Human Cells, Tissues and Organs, A Report Prepared by Elettra Ronchi, Paris: Organisation For Economic Co-Operation And Development.
OECD. 1996. Advances in Transplantation Biotechnology. Animal to Human Organ Transplants. - Xenotransplantation, Paris: Organisation for Economic Cooperation and Development.
OECD/NYAS. 1998. “Xenotransplantation: Scientific Frontiers and Public Policy” Ann. NY Acad. Sci., Vol. 862, pp. 1–251.
Oman Daily Observer. 1997. “Organ Transplant Doctor Held” Jan. 11.
Patience, C., Takeuchi, Y. & Weiss, R.A. 1997. “Infection of Human Cells by an Endogamous Retrovirus of Pigs” Nature Medicine, Vol. 3, pp. 282–286.
PHS. 1996. “Public Health Service, Draft Guidelines on Infectious Disease Issues in Xenotransplantation” Fed. Register, Vol. 61(185), pp. 49919–49932.
Platt, J.L. & Lin, S.S. 1998. “The Future Promises of Xenotransplantation. Xenotransplantation: Scientific Frontiers and Public Policy” Ann. NY Acad. Sci., Vol. 862, pp. 5–18.
Reemtsma, K. et al. 1964. “Renal Hetero-Xenotransplantation in Man” Ann. Surg., Vol. 160, pp. 384–410.
Regan, T. 1983. The Case for Animal Rights, Berkeley: Univ. of California Press.
Russel, W.M.S. & Burch, R.L. 1959. The Principles of Humane Experimental Technique, London: Methuen.
Sachs, D.H. et al. 1998. “Xenotransplantation Caution, But No Moratorium” Nature Medicine, Vol. 4(4), pp. 372–373.
Salomon, D.R., Ferguson, R.M. & Helderman, J.H. 1998. “Xenotransplants: Proceed With Caution” Nature, Vol. 392(6671), pp. 11–12.
Sandrin, M.S. et al. 1993. “Anti-Pig IgM Antibodies in Human Serum React Predominantly with Gala(1,3) Gal Epitopes” Proc. Natl. Acad. Sci. USA, Vol. 90, pp. 11391–11395.
Sandrin, M.S. et al. 1995. “Enzymatic Remodelling of the Carbohydrate Surface of a Xenogeneic Cell Substantially Reduces Human Antibody Binding and Complement-Mediated Cytosis” Nature Medicine, Vol. 1, pp. 1261–1267.
Sells, R.A. 1996. “Ethics of Xenotransplantation” Xeno, Vol. 4(2), pp. 18–20.
Shamblott, M.J. et al. 1998. “Derivation of Pluripotent Stem Cells from Cultured Human Primordial Germ Cells” Proc Natl Acad Sci USA, Vol. 95(23), pp. 13726–13731.
Sharma, A. et al. 1996. “Reduction in the Level of Gal (a1,3) Gal in Transgenic Mice and Pigs by the Expression of an a(1,2) Fucosyltransferase” Proc Natl Acad Sci USA, Vol. 93, pp. 7190–7195.
Singer P. 1975. Animal Liberation, New York: Random House.
Starzl, T.E. et al. 1993. “Baboon-to-Human Liver Transplantation” Lancet, Vol. 341(8837), pp. 65–71.
Stoye, J.P., Tissier, P.L., Takeuchi, Y., Patience, C. & Weiss, R.A. 1998. Endogenous Retroviruses: A Potential Problem for Xenortransplantation? Xenotransplantation. Scientific Frontiers and Public Policy. Ann. NY Acad. Sci. 862: 67–74.
Tearle, R.G. et al. 1996. “The a-1,3-Galactosyltransferase Knockout Mouse” Transplantation, Vol. 61, pp. 13–49.
Thall, A.D., Maly, P. & Lowe, J.B. 1997. “Oocyte Galal,3Gal Epitopes Implicated in Sperm Adhesion to the Zone Pellucida Glycoprotein ZP3 are Not Required for Fertilization in the Mouse” J Biol Chem, Vol. 270, pp. 21437–21440.
Thomson, J.A. et al. 1998. “Embryonic Stem Cell Lines Derived from Human Blastocysts” Science, Vol. 282, pp. 1145–1147.
Valpy, M. 1998. “Salvage Group Tackles Sick Kids’ Image Disaster. Business, Medical Ethics Split on Hospital Support for Doctor” The Globe and Mail, Monday, November 2, 12.
Wade, N. 1998. “Human Cells Revert to Embryo State, Scientists Assert” NY Times, Nov. 12.
Weiss, R. 1998. “Transgenic Pigs and Virus Adaptation” Nature, Vol. 391, pp. 327–328.
White, D. & Wallwork, J. 1993. “Xenografting: Probability, Possibility, or Pipe Dream? Lancet, Vol. 342, pp. 879–880.
WHO. 1998. “Report of World Health Organization Consultation on Xenotransplantation” Geneva, OSwitzerland, Oct. 28–30, 1997. WHO/EMC/ZO0198.2. Feb. 1998.
Williams, R.D. 1996. “Organ Transplants for Animals: Examining the Possibilities” USFDA Homepage.
Witt, C.J., Meslin, F-X & Heymann, D. 1997. “Emerging and Other Communicable Disease Surveillance and Control (EMC) Draft World Health Organization Recommendations on Xenotransplantation and Infectious Disease Prevention” WHO, Geneva, Switzerland.
World Health Assembly. 1999. “Cloning in Human Health” Report by Secretariat. Provisional Agenda Item 13. (WHA A52/12). April 1, 1999. For WHA in May, 1999.
Youngner, S.J. & Arnold, R.M. 1993. “Ethical, Psychological, and Public Policy Implications of Procuring Organs from Non-Heart Beating Cadaver Donors” JA MA, pp. 2769–2774.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Daar, A.S. (1999). Xenotransplantation. In: Caulfield, T.A., Williams-Jones, B. (eds) The Commercialization of Genetic Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4713-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4713-6_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7135-9
Online ISBN: 978-1-4615-4713-6
eBook Packages: Springer Book Archive